Pregnane X receptor deletion induces a lean phenotype in chow-fed mice through a liver–ileum–muscle axis involving 6α-hydroxylated bile acids and Fgf15
Abstract
Objectives The pregnane X receptor (Pxr; Nr1i2 ) plays a role in metabolic regulation. However, its contribution to systemic energy homeostasis under physiological conditions remains unclear. Here, we investigated the metabolic consequences of Nr1i2 deficiency in chow-fed mice. Methods Phenotyping was performed in adult whole-body Nr1i2 knockout ( Nr1i2 -/- ) chow-fed mice and their wild-type littermates. Body composition, metabolic parameters, skeletal muscle mass and myofiber size were assessed. Ileal gene expression, circulating Fgf15 levels, and bile acid composition were analyzed. Intestinal-specific Nr1i2 -/- mice were generated to evaluate the contribution of intestinal Pxr signaling. Mechanistic studies were conducted in HT29 cells and mouse ileal organoids. Results Chow-fed Nr1i2 -/- mice displayed a lean phenotype with reduced adiposity, improved insulin sensitivity, and increased skeletal muscle mass and myofiber size compared with wild-type mice. This phenotype was associated with strong induction of ileal Fgf15 gene expression and elevated circulating Fgf15 levels. Intestinal-specific Nr1i2 deletion did not reproduce the metabolic or muscular phenotype, indicating that intestinal Pxr loss alone is insufficient. Nr1i2 deficiency was associated with remodeling of the hepatic bile acid pathway and enrichment of specific taurine-conjugated and 6α-hydroxylated bile acids in the ileum. In vitro , these bile acids enhanced FGF19 expression through FXR-related canonical and non-canonical mechanisms, supporting a mechanistic link between bile acid remodeling and increased Fgf15/19 signaling. Conclusions These findings provide the first evidence that, under standard dietary conditions, loss of Pxr induces a lean phenotype, promotes reduced adiposity together with remodeling of bile acid pool, increased Fgf15 production and enhanced skeletal muscle mass.
Related
- The Pregnane X Receptor (PXR) contributes to phenotypic plasticity and modulates the sensitivity to targeted therapies in melanoma
- Sulforaphane Attenuates Antipsychotic-Elicited Hypercholesterolemia Through Inhibition of Pregnane X Receptor
- An integrated structural and functional profiling approach uncovers the mechanisms of pregnane X receptor binding and activation by pharmaceutical and environmental compounds
- Functional Roles of Adenosine A2B and A3 Receptor Subtypes in the Bladder of Male Rats With A2B Receptor Deletion or Bladder Outlet Obstruction
- A conditional, myeloid-cell specific estrogen receptor α deletion reprograms the liver immune microenvironment and impedes the growth of colon carcinoma liver metastases
BibTeX
@article{benoit2026pregnane,
title = {{Pregnane X receptor deletion induces a lean phenotype in chow-fed mice through a liver–ileum–muscle axis involving 6α-hydroxylated bile acids and Fgf15}},
author = {Bérengère Benoit and Audrey Jalabert and Emmanuelle Meugnier and Stéphanie Chanon and Aurélie Vieille-Marchiset and Alice Beau and Sandra Pesenti and Emmanuelle Loizon and Oriane Vitalis and Nadia Bendridi and Margaux Nawrot and Kassem Makki and Brigitte Le Magueresse-Battistoni and Jennifer Rieusset and Marie-Caroline Michalski and Dominique Rainteau and Karim Chikh and Hubert Vidal and Jérôme Ruzzin},
journal = {Molecular metabolism},
year = {2026},
month = sep,
doi = {10.1016/j.molmet.2026.102442},
url = {https://hal.science/hal-05762570v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Pregnane X receptor deletion induces a lean phenotype in chow-fed mice through a liver–ileum–muscle axis involving 6α-hydroxylated bile acids and Fgf15
AU - Bérengère Benoit
AU - Audrey Jalabert
AU - Emmanuelle Meugnier
AU - Stéphanie Chanon
AU - Aurélie Vieille-Marchiset
AU - Alice Beau
AU - Sandra Pesenti
AU - Emmanuelle Loizon
AU - Oriane Vitalis
AU - Nadia Bendridi
AU - Margaux Nawrot
AU - Kassem Makki
AU - Brigitte Le Magueresse-Battistoni
AU - Jennifer Rieusset
AU - Marie-Caroline Michalski
AU - Dominique Rainteau
AU - Karim Chikh
AU - Hubert Vidal
AU - Jérôme Ruzzin
PY - 2026
DA - 2026/09/24
JO - Molecular metabolism
DO - 10.1016/j.molmet.2026.102442
UR - https://hal.science/hal-05762570v1
AB - Objectives The pregnane X receptor (Pxr; Nr1i2 ) plays a role in metabolic regulation. However, its contribution to systemic energy homeostasis under physiological conditions remains unclear. Here, we investigated the metabolic consequences of Nr1i2 deficiency in chow-fed mice. Methods Phenotyping was performed in adult whole-body Nr1i2 knockout ( Nr1i2 -/- ) chow-fed mice and their wild-type littermates. Body composition, metabolic parameters, skeletal muscle mass and myofiber size were assessed. Ileal gene expression, circulating Fgf15 levels, and bile acid composition were analyzed. Intestinal-specific Nr1i2 -/- mice were generated to evaluate the contribution of intestinal Pxr signaling. Mechanistic studies were conducted in HT29 cells and mouse ileal organoids. Results Chow-fed Nr1i2 -/- mice displayed a lean phenotype with reduced adiposity, improved insulin sensitivity, and increased skeletal muscle mass and myofiber size compared with wild-type mice. This phenotype was associated with strong induction of ileal Fgf15 gene expression and elevated circulating Fgf15 levels. Intestinal-specific Nr1i2 deletion did not reproduce the metabolic or muscular phenotype, indicating that intestinal Pxr loss alone is insufficient. Nr1i2 deficiency was associated with remodeling of the hepatic bile acid pathway and enrichment of specific taurine-conjugated and 6α-hydroxylated bile acids in the ileum. In vitro , these bile acids enhanced FGF19 expression through FXR-related canonical and non-canonical mechanisms, supporting a mechanistic link between bile acid remodeling and increased Fgf15/19 signaling. Conclusions These findings provide the first evidence that, under standard dietary conditions, loss of Pxr induces a lean phenotype, promotes reduced adiposity together with remodeling of bile acid pool, increased Fgf15 production and enhanced skeletal muscle mass.
SN - 2212-8778
ER -